The Strange Case of Molecular Medicine

作者: Martin Paul

DOI: 10.1007/978-94-015-9708-1_8

关键词:

摘要: “Modern medicine is entering the “molecular age” — a statement similar to this frequently found not only in writings of physicians and scientists, but also mass media. Like many paradigm shifts that have characterized technical progress medical arena, characterization diseases at level genes molecules latest step search for final frontier medicine. Over past centuries, research has continuously refined its organization, as it focussed on whole body, then levels organ, cell, now, finally, genes. The term medicine” describes impact molecular biology genetics characterizes new field devoted aspects disease etiology, potential use resulting technology diagnosis therapy. human genome project now been completed, generating an abundance genetic information can be applied New candidate will defined tested functional models. This used ways: DNA useful define risk factors long before they appear, opening door preventive strategies. Furthermore, optimize conventional pharmacological treatment, improving rate responders drug treatment which currently low situations. means individual gene profile choose best option patient. Lastly, therapeutic approaches proposed using somatic transfer technology. These techniques are targeting repair defective genes, altering regulation by increasing “good” inhibiting “bad” Alternatively, replace or thought protective pathophysiological conditions added organism. All these offer fascinating ways allow tremendous

参考文章(12)
Charles R Yates, Eugene Y Krynetski, Thrina Loennechen, Michael Y Fessing, Hung-Liang Tai, Ching-Hon Pui, Mary V Relling, William E Evans, Molecular diagnosis of thiopurine S-methyltransferase deficiency: Genetic basis for azathioprine and mercaptopurine intolerance Annals of Internal Medicine. ,vol. 126, pp. 608- 614 ,(1997) , 10.7326/0003-4819-126-8-199704150-00003
K S Lown, D G Bailey, R J Fontana, S K Janardan, C H Adair, L A Fortlage, M B Brown, W Guo, P B Watkins, Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression. Journal of Clinical Investigation. ,vol. 99, pp. 2545- 2553 ,(1997) , 10.1172/JCI119439
William E. Evans, Mary V. Relling, Pharmacogenomics: Translating Functional Genomics into Rational Therapeutics Science. ,vol. 286, pp. 487- 491 ,(1999) , 10.1126/SCIENCE.286.5439.487
Kathreena M. Kurian, Christine J. Watson, Andrew H. Wyllie, DNA chip technology The Journal of Pathology. ,vol. 187, pp. 267- 271 ,(1999) , 10.1002/(SICI)1096-9896(199902)187:3<267::AID-PATH275>3.0.CO;2-#
M Paul, J Wagner, S Hoffmann, H Urata, D Ganten, Transgenic Rats: New Experimental Models for the Study of Candidate Genes in Hypertension Research Annual Review of Physiology. ,vol. 56, pp. 811- 829 ,(1994) , 10.1146/ANNUREV.PH.56.030194.004115
Tammy Kielian, William F. Hickey, Inflammatory thoughts about glioma gene therapy. Nature Medicine. ,vol. 5, pp. 1237- 1238 ,(1999) , 10.1038/15188
EWFW Alton, M Stern, R Farley, A Jaffe, SL Chadwick, J Phillips, J Davies, SN Smith, J Browning, MG Davies, ME Hodson, SR Durham, D Li, PK Jeffery, M Scallan, R Balfour, SJ Eastman, SH Cheng, AE Smith, D Meeker, DM Geddes, Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial. The Lancet. ,vol. 353, pp. 947- 954 ,(1999) , 10.1016/S0140-6736(98)06532-5
R. W. Moreadith, Nina Butwell Radford, Gene targeting in embryonic stem cells: the new physiology and metabolism. Journal of Molecular Medicine. ,vol. 75, pp. 208- 216 ,(1997) , 10.1007/S001090050105
Yoseph Caraco, Genetic determinants of drug responsiveness and drug interactions. Therapeutic Drug Monitoring. ,vol. 20, pp. 517- 524 ,(1998) , 10.1097/00007691-199810000-00012